Marker Therapeutics is trading 5.22% down at $1.09 after no clear company-specific announcement or catalyst was identified for August 11, 2026.
- The decline follows a $1.15 close on August 10, 2026.
- Broader indexes are modestly lower, including the Nasdaq Composite at -0.44%, but that weakness is insufficient to establish a direct macro cause.
- Trading activity and volume details were unavailable.